Timothy S. Pardee

Dr. Pardee is a Professor of Medicine and the Director of the Leukemia Program at the Comprehensive Cancer Center of Wake Forest Baptist Medical Center. He heads an NCI-funded research program focused on the role of cellular metabolism in cancer cell survival and resistance to therapy as well as novel therapeutics. Dr. Pardee has played a lead role in the development of the novel metabolism-targeting agent CPI-613® (devimistat). He earned his M.D. and his Ph.D. from SUNY Buffalo.